Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371031 · ClinicalTrials.gov registry record · Phase 1
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
A Phase 1 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT02371031 is a Phase 1 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 11 participants.
The verdict
NCT02371031, a Phase 1 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This is a pilot study designed to evaluate the potential of using FDOPA-PET/MRI for improving surgical planning and providing non-invasive prognostic information in patients with gliomas that have substantial non-enhancing regions. The results will be used to develop larger adequately powered studies.
Interventions
- DEVICE PET/MRI
- PROCEDURE Surgical resection (standard of care)
- DRUG 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371031
The ClinicalTrials.gov registry entry for NCT02371031 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PET/MRI is the first listed.
NCT02371031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02371031 about?
NCT02371031 is a clinical study titled "FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas". This is a pilot study designed to evaluate the potential of using FDOPA-PET/MRI for improving surgical planning and providing non-invasive prognostic information in patients with gliomas that have substantial non-enhancing regions. The results will be used to develop larger adequately powered studie...
What is the current status of trial NCT02371031?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2015-03. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02371031?
The interventions under investigation include: PET/MRI (DEVICE), Surgical resection (standard of care) (PROCEDURE), 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine (DRUG).
Who is sponsoring clinical trial NCT02371031?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.